CD93: A C-Type Lectin Domain Family Member with Roles in Cell Adhesion and Immune Regulation

Comprehensive genomic and proteomic overview of CD93, including expression, mutations, and disease associations.

Gene Information Card

Symbol CD93
Full Name CD93 molecule
Gene Type protein-coding
Chromosomal Location 20p11.21
NCBI Gene ID 22918 ncbi.nlm.nih.gov/gene/22918
Ensembl ID ENSG00000125826
UniProt ID Q9NPY3
OMIM ID 606043
HGNC ID 1690
Aliases C1qRP, C1qR(P), C1qRp, dJ737E23.1, MXRA4

Description

CD93 encodes a transmembrane glycoprotein belonging to the C-type lectin domain family. The protein functions as a receptor for C1q, mannose-binding lectin, and other ligands, playing roles in cell adhesion, phagocytosis, angiogenesis, and immune regulation. It is expressed on endothelial cells, monocytes, and hematopoietic stem cells, and is implicated in inflammation, vascular development, and tumor biology.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) CD93 overexpression promotes tumor angiogenesis and immune evasion; altered expression correlates with poor prognosis. Multiple studies in COSMIC and literature (e.g., PMID: 25605274, 30348676)
Inflammatory disorders CD93 mediates leukocyte adhesion and migration; dysregulation linked to chronic inflammation. Functional studies (e.g., PMID: 12421930, 19124732)
Cardiovascular disease CD93 involved in endothelial cell function and vascular remodeling; associated with atherosclerosis. Association studies (e.g., PMID: 21536682)

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 24.5 High
Spleen 20.1 High
Bone marrow 18.7 High
Heart 12.3 Medium
Liver 8.9 Medium
Brain 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HUVEC (endothelial) 35.2 High expression; used in angiogenesis studies
THP-1 (monocyte) 28.6 High expression; role in phagocytosis
HeLa (cervical) 12.1 Moderate expression
MCF7 (breast) 9.8 Moderate expression
A549 (lung) 15.4 Moderate-high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.124G>A (p.Gly42Arg) Missense <0.01% Unknown; rare variant in population databases
c.568C>T (p.Arg190Trp) Missense <0.01% Unknown; reported in ClinVar as uncertain significance
c.1021_1023del (p.Leu341del) In-frame deletion <0.01% Unknown; rare in COSMIC
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in CD93; knockout models show impaired phagocytosis and angiogenesis.

Gain of Function (GOF)

Overexpression of wild-type CD93 in tumors is associated with enhanced angiogenesis and metastasis; no activating mutations described.

Dominant Negative (DN)

No dominant-negative mutations reported for CD93.

Pathways

• Complement cascade (C1q-mediated)
• Angiogenesis (VEGF-independent)
• Cell adhesion and migration

Protein Summary

CD93 is a 652-amino-acid type I transmembrane protein with an N-terminal C-type lectin-like domain, a mucin-like stalk, a transmembrane region, and a short cytoplasmic tail. It is heavily glycosylated and localizes to the plasma membrane. The protein binds C1q and other ligands, mediating phagocytosis in myeloid cells and promoting endothelial cell adhesion, migration, and tube formation. CD93 is a key regulator of vascular integrity and immune surveillance.

Related Products

Product name Cat.No. Species Gene ID
CD93 Knockout HEK293 Cell Line EDJ-KQ1973 Human 22918 Details Get a Quote
CD93 Knockout HeLa Cell Line EDJ-KQ55657 Human 22918 Details Get a Quote
CD93 Knockout A-549 Cell Line EDJ-KQ64156 Human 22918 Details Get a Quote
CD93 Knockout HCT 116 Cell Line EDJ-KQ72602 Human 22918 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: